Brought to you by 
Cardiome acquires Artesian Therapeutics
10 Oct 2013
Executive Summary
Cardiome Pharma (developing therapeutics for atrial arrhythmia and congestive heart failure (CHF)) has acquired fellow cardiovascular company Artesian Therapeutics for payments that include earnouts of up to $32mm for each of Artesian's first two compounds to reach NDA approval.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Intra-Biotech Deal
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cardiome acquires Artesian Therapeutics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice